HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative studies between Japanese and Korean patients: comparison of the findings of angiography, HLA-Bw52, and clinical manifestations.

Abstract
A Japan-Korea cooperative survey on Takayasu arteritis has shown some differences in the features between Japanese and Korean patients with this disease. In angiographic findings, Japanese patients more frequently had lesions at the aortic arch and/or its branches (58% of 75 cases), while, in Korean patients, the abdominal aorta is the site of relatively frequent lesions (30% of 112 cases). Higher occurrence of HLA-Bw52 was found in Japanese patients in comparison with Korean patients (46% vs 15%). The presence of HLA-Bw52, however, might have a close association with Takayasu arteritis in Korea as well as in Japan. The complications in 126 Japanese and 88 Korean patients were also compared. The complications occurring with higher frequency in Japanese patients were aortic regurgitation, ischemic heart disease, and visual disturbances, while, in Korean patients, the more frequent complications were renovascular hypertension as well as hypertension of some other etiology.
AuthorsM Yajima, R Moriwaki, F Numano, Y B Park, Y D Cho
JournalHeart and vessels. Supplement (Heart Vessels Suppl) Vol. 7 Pg. 102-5 ( 1992) ISSN: 0935-736X [Print] Japan
PMID1360952 (Publication Type: Journal Article)
Chemical References
  • HLA-B Antigens
  • HLA-B52 Antigen
Topics
  • Adolescent
  • Adult
  • Aged
  • Angiography
  • Aortography
  • Cause of Death
  • Cross-Cultural Comparison
  • Female
  • Gene Frequency (genetics)
  • Genetics, Population
  • HLA-B Antigens (genetics)
  • HLA-B52 Antigen
  • Humans
  • Japan
  • Korea
  • Male
  • Middle Aged
  • Phenotype
  • Takayasu Arteritis (diagnostic imaging, genetics, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: